Literature DB >> 17072823

Regression analysis of failure time data with informative interval censoring.

Zhigang Zhang1, Liuquan Sun, Jianguo Sun, Dianne M Finkelstein.   

Abstract

Interval censoring arises when a subject misses prescheduled visits at which the failure is to be assessed. Most existing approaches for analysing interval-censored failure time data assume that the censoring mechanism is independent of the true failure time. However, there are situations where this assumption may not hold. In this paper, we consider such a situation in which the dependence structure between the censoring variables and the failure time can be modelled through some latent variables and a method for regression analysis of failure time data is proposed. The method makes use of the proportional hazards frailty model and an EM algorithm is presented for estimation. Finite sample properties of the proposed estimators of regression parameters are examined through simulation studies and we illustrate the method with data from an AIDS study. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17072823     DOI: 10.1002/sim.2721

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Semiparametric regression analysis of interval-censored data with informative dropout.

Authors:  Fei Gao; Donglin Zeng; Dan-Yu Lin
Journal:  Biometrics       Date:  2018-06-05       Impact factor: 2.571

2.  Weighted logrank tests for interval censored data when assessment times depend on treatment.

Authors:  Michael P Fay; Joanna H Shih
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

Review 3.  Interval censoring.

Authors:  Zhigang Zhang; Jianguo Sun
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

4.  Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package.

Authors:  Michael P Fay; Pamela A Shaw
Journal:  J Stat Softw       Date:  2010-08       Impact factor: 6.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.